WO2016207095A1

WO2016207095A1 - Sprayable sun protection agents with a defined wax mixture

Info

Publication number: WO2016207095A1
Application number: PCT/EP2016/064129
Authority: WO
Inventors: Heike Lerg; Andreas Bleckmann; Katrin Weinert
Original assignee: Beiersdorf Ag
Priority date: 2015-06-25
Filing date: 2016-06-20
Publication date: 2016-12-29
Also published as: DE102015212122A1; EP3313358A1

Abstract

The invention relates to a cosmetic preparation containing a) one or more UV filters, b) a wax mixture of paraffin, Copernicia Cerifera Cera, Glycol Montanate and Shorea Robusta Resin.

Description

description

Sprayable sunscreen with defined wax mixture

The present invention relates to a cosmetic preparation containing one or more UV filters, and a wax mixture of paraffin, Copericia Cerifera Cera, Glycol Montanate and Shorea Robusta Resin.

The trend away from sophisticated paleness to "healthy, sporty brown skin" has been unbroken for years, and people are exposing their skin to sunlight, as it causes pigmentation in the sense of melanin formation, which has ultraviolet radiation from sunlight In addition to the acute injury (sunburn), long-term damage such as an increased risk of skin cancer due to excessive exposure to UVB light

(Wavelength: 280-320 nm). The excessive action of the UVB and UVA radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous phototoxic and photoallergic reactions and leads to premature skin aging.

To protect the skin, therefore, a number of sunscreen filter substances have been developed which can be used in cosmetic preparations. These UVA and UVB filters are summarized in most industrialized countries in the form of positive lists such as Appendix 7 of the Cosmetics Regulation.

However, the variety of commercially available sunscreens must not obscure the fact that these prior art formulations have a number of disadvantages.

A special form of cosmetic sunscreen agents are the sprayable preparations, which are prepared by means of a spray applicator with spray head either by means of a mechanical spray Delivery pump or by means of a propellant gas from a storage container to be applied to the skin. Such preparations are subject to a number of requirements which, in their entirety, are often difficult to reconcile.

Thus, the preparations should ensure a good UV protection, it should feel pleasant on the skin, be easy to spray (ie be easy to remove from the reservoir and thereby be consistent, spread over the skin over a large area) and not be so thin, that after application to the skin they immediately flow down, but show a certain "adhesion" on the skin, in order to then again be easy and evenly distributed on the skin.

In particular, there is a difficulty in balancing good sprayability with regard to the spray pattern (ie uniform, large-area distribution of the preparation on the skin in the form of small, uniform droplets) and the viscosity or flow behavior of the preparation and its spreadability after application to the skin to ensure.

Preparations of the state of the art either run so thinly that they emerge from the applicator during the pump spray in the form of a focused jet of "water pistols" or the preparations are so viscous that they can no longer be properly sprayed and distributed on the skin.

It was therefore an object of the present invention to develop a sprayable sunscreen, which is particularly suitable for use in pump sprays, which allows a uniform, large-area distribution on the skin in the form of small, uniform droplets without being so thin that it after instantly dripped from the skin. The sunscreen should be sensory and easy to distribute on the skin and of course allow sufficient UV protection of the same.

Since the person skilled in the art is naturally aware that the design of the spray head of the spray applicator also has an influence on the spray pattern, the comparison of

Of course, always spray images on the use of the same spray head. However, the task described should be independent of the spray head type for all customary in cosmetics

Spray heads are released.

The object is surprisingly achieved by a cosmetic preparation comprising a) one or more UV filters, b) a wax mixture of paraffin, Copericia Cerifera Cera, Glycol Montanate and Shorea Robusta Resin.

The wax mixture according to the invention may i.a. at Kahl GmbH & Co KG under the trade name "Kahlwax 7304".

Although the person skilled in the art knows DE19726783, DE 19726786, DE 102012224158, DE 19645318, DE 19645319, DE 19645320, DE 102004052833, DE 102008021631 and DE 102006006864, these documents did not show the way to the present invention.

It is inventively advantageous if the preparation of the wax mixture in a

Concentration of 0.3 to 5% by weight, based on the total weight of the preparation contains.

It is inventively preferred if the preparation of the wax mixture in a

Concentration of 0.5 to 3% by weight, based on the total weight of the preparation contains.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation contains one or more UV filters selected from the group of the compounds 2-phenylbenzimidazole-5-sulphonic acid and / or salts thereof;

Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidenemethyl) benzene sulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2,2'-methylene-bis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-Benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] phenol ; 3- (4-methylbenzylidene) camphor; 3-benzylidenecamphor; ethylhexyl salicylate;

Terephthalidendicamphersulfonsäure; 4- (tert-butyl) -4'-methoxydibenzoylmethane; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester; 4- (dimethylamino) benzoic acid amyl ester; 4-Methoxybenzalmalon-säuredi (2-ethylhexyl) ester; 4-methoxycinnamic acid (2-ethylhexyl) ester; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate;

homomenthyl; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzalmalonate; 3- (4- (2,2-bisethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer; Dioctylbutylamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine; 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine having the (CAS No 288254-16-0); 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (also: 2,4,6-tris [anilino] (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone); 2,4,6-tribiphenyl-4-yl-1,3,5-triazine Merocyanines; piperazine derivatives; titanium dioxide; zinc oxide.

In this case, it is preferred according to the invention if the preparation contains no 3- (4-methylbenzylidene) camphor, 2-hydroxy-4-methoxybenzophenone (INCI: oxybenzone) and ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: octocrylene) , so be free from these ingredients.

It is preferred according to the invention if the preparation according to the invention contains 2-phenylbenzimidazole-5-sulfonic acid salts.

In such a case, it is preferred according to the invention if the preparation contains 2-phenylbenzimidazole-5-sulfonic acid salts in a concentration of 1 to 4% by weight, based on the total weight of the preparation.

The use of sodium or potassium salts according to the invention is advantageous.

Preference is also the use of 2-ethylhexyl 2-hydroxybenzoate (INCI: ethylhexyl salicylates).

Contains the preparation as salicylate 2-ethylhexyl 2-hydroxybenzoate (INCI: ethylhexyl salicylates), it is according to the invention advantageous to use this in a concentration of 3 to 5% by weight, based on the total weight of the preparation.

Contains the preparation as salicylate 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate (INCI:

Homosalates), it is according to the invention advantageous to use this in a concentration of 3 to 10% by weight, based on the total weight of the preparation.

If the preparation contains both salicylates, it is advantageous according to the invention 2-ethylhexyl 2-hydroxybenzoate (INCI: ethylhexyl salicylate) in a concentration of 2 to 5% by weight and 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate (INCI: homosalates) in a concentration of 2 to 10% by weight, based in each case on the total weight of the preparation. Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation according to the invention comprises 2,4,6-tris [anilino (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine ( INCI: ethylhexyl triazone).

It is advantageous according to the invention if the preparation according to the invention 2,4,6-tris [anilino (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone ) in an amount of 2 to 5% by weight, based on the total weight of the preparation.

It is advantageous for the purposes of the present invention, when the preparation of the invention 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3rd , 5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines).

In such a case, it is inventively advantageous if the inventive

Preparation 2,4-Bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines ) in an amount of 2 to 5% by weight, based on the total weight of the preparation.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation has a viscosity of 300 to 1200 mPas.

The viscosity values of the preparations and individual substances listed in the present specification were determined with the aid of a Viskotester VT 02 viscometer from the company Haake (temperature: 25 ° C., spindle diameter 23 mm,

Rotor speed 62.5 1 / min).

It is advantageous according to the invention if the wax mixture according to the invention has the following composition (based on the total amount of the wax mixture):

Paraffin 50-75% by weight, Copericia cerifera Cera 25-50% by weight, glycol montanate 5-10% by weight, Shorea robusta resin 5-10% by weight.

It is advantageous according to the invention if the preparation is in the form of an emulsion. It is preferred according to the invention if the preparation is in the form of an O / W emulsion.

If the preparation according to the invention is in the form of an emulsion, then the

According to the invention advantageous embodiments characterized in that the Preparation contains one or more emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid,

Stearate salts, polyglyceryl-3-methylglycose distearate, sodium cetearylsulfate,

Sodium staroylglutamate, polyglyceryl-10 stearate, cetearyl alcohol, cetearyl sulfosuccinate, potassium cetyl phosphate. Polyglyceryl-6 Stearate and Polyglyceryl-6 Behenate, Ceteareth-20,

According to the invention, the total concentration of these emulsifiers in the preparation is from 0.1 to 4% by weight, based on the total weight of the preparation (ie if the preparation contains only one emulsifier, this concentration corresponds to

Individual concentration of this emulsifier).

The aqueous phase of the preparations according to the invention may advantageously contain customary cosmetic auxiliaries, such as, for example, isopropanol or polyols of low C number and their ethers, preferably propylene glycol, glycerol, electrolytes, self-tanning agents and in particular one or more thickening agents which can be advantageously selected from the group Silica, aluminum silicates, polysaccharides or their derivatives, for. As hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose, particularly advantageous from the group of polyacrylates, preferably a polyacrylate from the group of so-called carbopols, for example Carbopols types 980, 981, 1382, 2984, 5984, each individually or in combination. Further thickeners which are advantageous according to the invention are those having the INCI name Acrylates / C 10-30 alkyl acrylate crosspolymer (eg Pemulen TR 1, Pemulen TR 2, Carbopol 1328 from NOVEON) and Aristoflex AVC (INCI: Ammonium Acryloyldimethyltaurate / VP copolymer).

It is preferred according to the invention, when the preparation contains xanthan gum, crosslinked acrylate / C10-C30 alkyl acrylate polymer and / or vinylpyrrolidone / hexadecene copolymer.

A content of glycerol of at least 5% by weight, based on the total weight of the preparation, is particularly advantageous according to the invention.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation is free of parabens, methylisothiazolinone,

Chloromethylisothiazolinone and DMDM hydantoin. It is furthermore advantageous for the purposes of the present invention if the preparation according to the invention comprises one or more perfume substances selected from the group of the compounds limonene, citral, linalool, alpha-isomethylionone, geraniol, citronellol, 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert-pentylcyclohexyl acetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1, 1, 3,4,4,6-hexamethyltetralin, adipic acid diester, alpha-amylcinnamaldehyde, alpha-methylionone, amyl C butylphenylmethylpropionalcinnamal, Amyl salicylate, amyl cinnamyl alcohol, aniseed alcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate,

Bergamot oil, bitter orange oil, butylphenylmethylpropioal, cardamom oil, cedrol, cinnamal, cinnamyl alcohol, citronellylmethyl crotonate, citrus oil, coumarin, diethyl succinate, ethyllinalool, eugenol, Evernia furfuracea extract, Evernia prunastri extract, farnesol, guaiac wood oil, hexyl cinnamal, hexyl salicylate, hydroxycitronellal, lavender oil, lemone oil, linayl acetate , Mandarin oil, menthyl PCA, methyl heptenone, nutmeg oil, rosemary oil, sweet orange oil, terpineol, tonka bean oil, triethyl citrate and / or vanillin.

According to the invention, the preparation according to the invention advantageously contains film formers. Film formers for the purposes of the present invention are substances of different composition, which are characterized by the following property: If a film former is dissolved in water or other suitable solvents and the solution is then applied to the skin, it forms a film after the solvent has evaporated Essentially, it serves to fix the light filters on the skin, thus increasing the water resistance of the product.

It is particularly advantageous to use the film formers from the group of polymers based on polyvinylpyrrolidone (PVP).

to choose. Particularly preferred are copolymers of polyvinylpyrrolidone, for example the PVP hexadecene copolymer, tricontanyl PVP, and the PVP eicosene copolymer, which are available under the trade names Antaron V216, Antaron WP-660 and Antaron V220 from Ashland.

Also advantageous are other polymeric film formers, such as, for example, sodium polystyrene sulfonate, which has been sold under the trade name Flexan 130 in the National Starch and Chemical Corp. and / or polyisobutene, available from Rewo under the tradename Rewopal PIB1000. Further suitable polymers are, for example, polyacrylamides (Seppigel 305), polyvinyl alcohols, PVP, PVP / VA copolymers, polyglycols, acrylate / octylacralimide copolymer (Dermacryl 79), acrylates copolymer (Epitex 66). Also advantageous is the use of hydrogenated castor oil Dimerdilinoleat (CAS 646054-62-8, INCI Hydrogenated Castor Oil Dimer Dilinoleate), which can be purchased from Kokyu Alcohol Kogyo under the name Risocast DA-H or PPG-3 Benzylethermyristat ( CAS 403517-45-3), which can be obtained under the trade name Crodamol STS from Croda Chemicals.

Embodiments of the present invention which are advantageous according to the invention are furthermore characterized in that the preparation comprises one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and / or or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, panthenol, magnolol, honokiol,

Tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or salts thereof and / or licochalcone A.

Advantageous embodiments in the context of the present invention are further characterized in that the preparation contains one or more alkanediols from the group of compounds 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol, 1, 2-decanediol, 2 Methyl-1, 3-propanediol contains.

According to the invention, the total concentration of these alkanediols in the preparation is from 0.5 to 5% by weight, based on the total weight of the preparation (that is, if the preparation contains only one alkanediol, this concentration corresponds to

Single concentration of this alkanediol).

In addition, it is advantageous according to the invention if the preparation contains phenoxyethanol and / or ethylhexylglycerol.

According to the invention, the total concentration of these substances in the preparation is advantageously from 0.5 to 5% by weight, based on the total weight of the preparation (ie if the preparation contains only phenoxyethanol or ethylhexylglycerol, this concentration corresponds to the individual concentration of that substance).

According to the invention, the use of the preparation according to the invention for protection against skin aging (in particular for protection against UV-induced skin aging) and as

Sunscreens.

Not least according to the invention is a spray applicator containing the cosmetic preparation according to the invention.

Comparative test

The following formulations were prepared, sprayed under identical conditions and the spray pattern evaluated by image analysis. inci approach 1 approach 2

Paraffin, Copernicia.Cerifera, Cera, Montan Acid, Wax, Shorea Robusta

Resin 1, 0

C 18-36 Acid triglycerides 1, 0

Tocopheryl Acetate 0.1 0.1

Panthenol + Aqua 1, 4 1, 4

Butylene Glycol Dicaprylate / Dicaprate 2.0 2.0

Ceteareth-20 1, 5 1, 5

VP / hexadecenes copolymer 1, 0 1, 0

Perfume 0.3 0.3

Glycerin + Aqua 5.0 5.0

Aqua + Sodium Hydroxide (attention - should not appear in the VDK) 0.9 0.9

Phenoxyethanol 0.5 0.5

Ethylparaben 0.2 0.2

Methyl paraben 0.3 0.3

Acrylates / C 10-30 Alkyl Acrylate Crosspolymer 0.4 0.4

Alcohol Denat. + Aqua 4.0 4.0

Aqua + Trisodium EDTA 1, 0 1, 0

Homosalates 9.0 9.0

Octocrylene 8.0 8.0

Ethyl hexyl salicylate 4.8 4.8

Bis-ethylhexyloxyphenol methoxyphenyl triazines 3,5 3,5

Butyl methoxydibenzoylmethane 4,5 4,5

Phenylbenzimidazole sulfonic acid 1, 5 1, 5

Aqua Ad 100 Ad 100

Method for creating a spray pattern:

The measurements were carried out under the following conditions:

Device: compressed air spray rack

Pressure regulator: 6 bar

Measuring temp .: 25 ° C

Damping: Damping screw open

(Pressure cylinder presses quickly on the spray head)

Spray distance 150 mm

Paper: Thermal paper Art: 5702-1221 from e-pa

The paper is heated with a hair dryer. The non-product-covered areas remain lighter than the rest of the paper.

This produces evaluable contrast images.

Execution of image analysis after contrast differences:

1. A region of interest is defined (ROI) in the evaluated

2. For the evaluation, the L value (brightness in the L ^* a ^* b color space) is considered

3. Two limit values for the L value are manually defined, so that the

found investigative features, but the background is not detected

4. the image is binarized: all pixels within the defined limits are black (= 0) and all other pixels are white (= 1)

5. Now all contiguous black surfaces are considered as an event

detects (Area Count) and determines its mean size (Area Avg Size)

6. the sum of all black pixels gives the absolute coverage (Absolute Coverage) 7. Relative to the size of the region of interest, the relative coverage results

Result: Spray image evaluation Image analysis after contrast differences

Interpretation of the results

Through the use of the raw material, a finer and more uniform distribution of the emulsion takes place, thus a better protection against harmful UV radiation can be ensured.

The absolutely covered area of the spray pattern (2), (3) of the emulsion with the raw material is significantly larger in the selected ROI size (1).

A finer distribution of the emulsion is evidenced by the higher number of single pixels (4) pixels in the ROI size (1) and at the same time small area (5) of the individual pixels. Examples

The following examples are intended to illustrate the present invention without limiting it. Unless indicated otherwise, all amounts, proportions and percentages are based on the weight and the total amount or on the total weight of the preparations.

inci 1 2 3 4 5

Paraffin, Copernicia, Cerifera, Cera, Montan Acid, 1, 00 1, 00 0.50 1, 00 2.00 Wax, Shorea Robusta Resin (Kahlwax 7304)

Tocopheryl acetates 0, 10 0,10 0, 10 0, 10 0,10

Panthenol + Aqua 1, 40 1, 40 1, 40 1, 40 1, 40

Butylene Glycol Dicaprylate / Dicaprate 2.00 1, 50 2.00 3.00 2.00

Ceteareth-20 1, 50 1, 50 1, 50 1, 00 2.00

VP / hexadecene copolymer 0.80 1, 00 1, 00 1, 50 1, 00

Perfume 0.30 0.30 0.30 0.30 0.30

Glycerine + Aqua 5.00 5.00 5.00 5.00 5.00

Aqua + Sodium Hydroxide (attention - should 0,90 0,90 0,90 0,90 0,90 not appear in the VDK)

Phenoxyethanol 0.50 0.50 0.50 0.50 0.50

Ethyl paraben 0.20 0.20 0.20 0.20 0.20

Methylparaben 0.30 0.30 0.30 0.30 0.30

Acrylates / C 10-30 Alkyl Acrylate Crosspolymer 0.30 0.40 0.60 0.40 0.10

Alcohol Denat. + Aqua 4.00 4.00 2.00 6.00 4.00

Aqua + Trisodium EDTA 1, 00 1, 00 1, 00 1, 00 1, 00

Homosalats 9,00 8,00 7,00 9,00 5,00

Octocrylene 3.00 6.00 8.00 9.00

Ethyl hexyl salicylates 4,80 4,80 4,80 5,00 5,00

Bis-ethylhexyloxyphenol Methoxyphenyl 3.50 3.50 3.50 3.50 3.50 Triazines

Butyl Methoxydibenzoylmethane 3.00 4.50 3.40 4.50 4.00

Phenylbenzimidazole sulfonic acid 1, 50 2.00 2.50 3.00

Aqua ad 100

Claims

claims

1. Cosmetic preparation containing

a) one or more UV filters,

b) a wax mixture of paraffin, Copericia Cerifera Cera, Glycol Montanate and Shorea Robusta Resin.

2. Cosmetic preparation according to claim 1, characterized in that the

Preparation containing the wax mixture in a concentration of 0.5 to 3% by weight, based on the total weight of the preparation.

3. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains one or more UV filters selected from the group of the compounds 2-phenylbenzimidazole-5-sulphonic acid and / or salts thereof; Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidenemethyl) benzenesulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2,2'-methylenebis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] -phenol; 3- (4-methylbenzylidene) camphor; 3-benzylidenecamphor;

ethylhexyl salicylate; Terephthalidendicamphersulfonsäure; 4- (tert-butyl) -4'-methoxydibenzoylmethane; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; 2-ethylhexyl 4- (dimethylamino) benzoate; 4- (dimethylamino) benzoic acid amyl ester; Di (2-ethylhexyl) -4-methoxybenzalmalonate; 4-methoxycinnamate (2-ethylhexyl) ester; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate; Homomenthylsahcylat; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzalmalonate; 3- (4- (2,2-bis

Ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer; Dioctylbutylamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine; 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine with the CAS No. 288254-16-0); 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (also: 2,4,6-tris [ anilino (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone); 2,4,6-tribiphenyl-4-yl-1,3,5 triazine; merocyanines;

Piperazine derivatives, titanium dioxide; Zinc oxide.

4. Cosmetic preparation according to one of the preceding claims, characterized in that the preparation has a viscosity 300 of up to 1500 mPas.

5. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the preparation is in the form of an emulsion.

6. Cosmetic preparation according to one of the preceding claims, characterized

in that wax mixture has the following composition (based on the total amount of the wax mixture): paraffin 50-75% by weight, Copericia Cerifera Cera 25-50% by weight, glycol montanate 5-10% by weight, Shorea Robusta Resin 5-10% by weight.

7. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the preparation is in the form of an O / W emulsion.

8. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains one or more emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, polyglyceryl-3-methylglycose distearate, sodium cetearyl sulphate, sodium staroylglutamate, polyglyceryl-10-stearate, cetearyl alcohol, cetearyl sulphosuccinate, potassium cetyl phosphate ,

9. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and / or synthetic isoflavotenoids, flavonoids, creatine , Creatinine, taurine, β-alanine, panthenol, magnolol, honokiol, tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or salts thereof and / or licochalcone A.

10. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains one or more alkanediols from the group of compounds 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol, 1, 2-decanediol, 2-methyl-1,3-propanediol.

1 1. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains phenoxyethanol and / or ethylhexylglycerol.

12. spray applicator containing a cosmetic preparation according to one of

previous claims.